NCT06606015View on ClinicalTrials.gov

Noninvasive Hemodynamics Assessment of Preterms With Successful Medical Closure of PDA

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Patent Ductus Arteriosus in Preterm Infants
Interventions
DRUG

I.V Paracetamol.

Pharmacological thereby for hsPDA closure in the preterm neonates.

DEVICE

Echocardiography.

It is routinely performed in neonates for PDA screening and detection of any other cardiac anomalies.

DEVICE

Electrical Cardiometry

Non invasive hemodynamics monitoring

Trial Locations (1)

31527

Faculty of Medicine, Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06606015 - Noninvasive Hemodynamics Assessment of Preterms With Successful Medical Closure of PDA | Biotech Hunter | Biotech Hunter